Welcome to IJSDR UGC CARE norms ugc approved journal norms IJRTI Research Journal | ISSN : 2455-2631
International Peer Reviewed & Refereed Journals, Open Access Journal
ISSN Approved Journal No: 2455-2631 | Impact factor: 8.15 | ESTD Year: 2016
Scholarly open access journals, Peer-reviewed, and Refereed Journals, Impact factor 8.15 (Calculate by google scholar and Semantic Scholar | AI-Powered Research Tool) , Multidisciplinary, Monthly, Indexing in all major database & Metadata, Citation Generator, Digital Object Identifier(DOI)

Issue: June 2022

Volume 7 | Issue 6

Impact factor: 8.15

Click Here For more Info

Imp Links for Author
Imp Links for Reviewer
Research Area
Subscribe IJSDR
Visitor Counter

Copyright Infringement Claims
Indexing Partner
Published Paper Details
Authors Name: Dipali A. Chavan , Ashok Muchandi , Sayali Rathod , Ankita Kamble , Kshiar shantilang
Unique Id: IJSDR2201032
Published In: Volume 7 Issue 1, January-2022
Abstract: Infection by the SARS-CoV-2 virus, known as COVID-19 (Corona Virus Disease-19), emerged in December 2019 in China and spread rapidly all around the world infecting many peopleand has subsequently spread rapidly throughout the world, however, well-designed studies on asymptomatic or mild, or pediatric cases of COVID-19 are scarce and desperately needed to meet the clinical need. However, a trend could be observed based on current clinical evidence. Remdesivir and favipiravir may shorten the recovery time; lopinavir/ritonavir does not demonstrate treatment efficacy in severe patients. In this review, we collected information about the most widely used drugs to treat COVID-19 (coronavirus disease 2019) belonging to groups of antivirals, antibiotics, immune modulators, and anticoagulants. Some of these compounds and drugs were used directly by inpatients, so researchers have examined others in laboratory conditions. The present study provides an update on the currently applied treatment, and intends to offer helpin relation to daily care, without seeking to replace the protocols adopted in each individual center.
Keywords: SARS-CoV-2, COVID-19, antiviral drugs, antibiotics, immune modulators, anticoagulants
Cite Article: "TREATMENT OF COVID-19 - A REVIEW", International Journal of Science & Engineering Development Research (www.ijsdr.org), ISSN:2455-2631, Vol.7, Issue 1, page no.224 - 230, January-2022, Available :http://www.ijsdr.org/papers/IJSDR2201032.pdf
Downloads: 00096793
Publication Details: Published Paper ID: IJSDR2201032
Registration ID:193890
Published In: Volume 7 Issue 1, January-2022
DOI (Digital Object Identifier):
Page No: 224 - 230
Publisher: IJSDR | www.ijsdr.org
ISSN Number: 2455-2631

Click Here to Download This Article

Article Preview

Click here for Article Preview

Major Indexing from www.ijsdr.org
Google Scholar ResearcherID Thomson Reuters Mendeley : reference manager Academia.edu
arXiv.org : cornell university library Research Gate CiteSeerX DOAJ : Directory of Open Access Journals
DRJI Index Copernicus International Scribd DocStoc

Track Paper
Important Links
Conference Proposal
DOI (A digital object identifier)

Providing A digital object identifier by DOI
How to GET DOI and Hard Copy Related
Open Access License Policy
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
Creative Commons License
This material is Open Knowledge
This material is Open Data
This material is Open Content
Social Media

Indexing Partner